• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构调节在神经元烟碱型乙酰胆碱受体中的特异性决定因素:抑制与增强之间的微妙界限。

Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiation.

机构信息

Department of Chemistry, Grinnell College, Grinnell, Iowa, USA.

出版信息

Mol Pharmacol. 2012 Feb;81(2):239-49. doi: 10.1124/mol.111.076059. Epub 2011 Nov 7.

DOI:10.1124/mol.111.076059
PMID:22064677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3263947/
Abstract

We are interested in the allosteric modulation of neuronal nicotinic acetylcholine receptors (nAChRs). We have postulated that the anthelmintic morantel (Mor) positively modulates (potentiates) rat α3β2 receptors through a site located at the β(+)/α(-) interface that is homologous to the canonical agonist site (J Neurosci 29:8734-8742, 2009). On this basis, we aimed to determine the site specificity by studying differences in modulation between α3β2 and α4β2 receptors. We also compared modulation by Mor with that of the related compound oxantel (Oxa). Whereas Mor and Oxa each potentiated α3β2 receptors 2-fold at saturating acetylcholine (ACh) concentrations, Mor had no effect on α4β2 receptors, and Oxa inhibited ACh-evoked responses. The inhibition was noncompetitive, but not due to open channel block. Furthermore, the nature and extent of modulation did not depend on subunit stoichiometry. We studied six positions at the α(-) interface that differ between α3 and α4. Two positions (α3Ile57 and α3Thr115) help mediate the effects of the modulators but do not seem to contribute to specificity. Mutations in two others (α3Leu107 and α3Ile117) yielded receptors with appreciable α4-character; that is, Mor potentiation was reduced compared with wild-type α3β2 control and Oxa inhibition was evident. A fifth position (α3Glu113) was unique in that it discriminated between the two compounds, showing no change in Mor potentiation from control but substantial Oxa inhibition. Our work has implications for rational drug design for nicotinic receptors and sheds light on mechanisms of allosteric modulation in nAChRs, especially the subtle differences between potentiation and inhibition.

摘要

我们对神经元烟碱型乙酰胆碱受体(nAChRs)的别构调节很感兴趣。我们假设驱虫药莫仑特(Mor)通过位于β(+)/α(-)界面的一个与经典激动剂位点同源的位点正向调节(增强)大鼠α3β2 受体(J Neurosci 29:8734-8742, 2009)。在此基础上,我们旨在通过研究α3β2 和 α4β2 受体之间的调节差异来确定该位点的特异性。我们还比较了 Mor 与相关化合物奥沙托嗪(Oxa)的调节作用。虽然 Mor 和 Oxa 都在饱和乙酰胆碱(ACh)浓度下使α3β2 受体增强 2 倍,但 Mor 对 α4β2 受体没有影响,而 Oxa 抑制 ACh 诱发的反应。这种抑制是非竞争性的,但不是由于开放通道阻塞引起的。此外,调节的性质和程度不依赖于亚基计量关系。我们研究了在α(-)界面上的六个位置,这些位置在α3 和α4 之间不同。两个位置(α3Ile57 和 α3Thr115)有助于调节因子的作用,但似乎不贡献于特异性。另外两个位置(α3Leu107 和 α3Ile117)的突变产生了具有明显α4 特征的受体,即与野生型α3β2 对照相比,Mor 增强作用降低,而 Oxa 抑制作用明显。第五个位置(α3Glu113)是独特的,它区分了这两种化合物,Mor 增强作用与对照相比没有变化,但 Oxa 抑制作用显著。我们的工作对烟碱型受体的合理药物设计具有启示意义,并阐明了 nAChRs 别构调节的机制,特别是增强作用和抑制作用之间的细微差异。

相似文献

1
Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiation.变构调节在神经元烟碱型乙酰胆碱受体中的特异性决定因素:抑制与增强之间的微妙界限。
Mol Pharmacol. 2012 Feb;81(2):239-49. doi: 10.1124/mol.111.076059. Epub 2011 Nov 7.
2
Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.亚基界面在神经元烟碱型乙酰胆碱受体的激活和变构调节中发挥不同作用。
Neuropharmacology. 2015 Apr;91:157-68. doi: 10.1016/j.neuropharm.2014.11.027. Epub 2014 Dec 5.
3
The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors.正变构调节剂莫仑太尔结合于神经元烟碱型乙酰胆碱受体的非典型亚基界面。
J Neurosci. 2009 Jul 8;29(27):8734-42. doi: 10.1523/JNEUROSCI.1859-09.2009.
4
Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.莫仑太尔可别构增强神经元烟碱型乙酰胆碱α3β2受体的通道门控。
Mol Pharmacol. 2008 Aug;74(2):466-75. doi: 10.1124/mol.107.044388. Epub 2008 May 5.
5
Intra-subunit flexibility underlies activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.亚基内的灵活性是神经元烟碱型乙酰胆碱受体激活和变构调节的基础。
Neuropharmacology. 2014 Apr;79:420-31. doi: 10.1016/j.neuropharm.2013.12.017. Epub 2013 Dec 25.
6
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.同型神经元烟碱型乙酰胆碱受体的变构正位增效作用。
Br J Pharmacol. 2018 Jun;175(11):1805-1821. doi: 10.1111/bph.13745. Epub 2017 Mar 20.
7
Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.α4β2 型神经元烟碱型乙酰胆碱受体的变构调节剂。
Biochem Pharmacol. 2011 Oct 15;82(8):952-8. doi: 10.1016/j.bcp.2011.04.020. Epub 2011 May 7.
8
Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.用一种(α4)3(β2)2烟碱型乙酰胆碱受体(nAChR)选择性正变构调节剂对烟碱型乙酰胆碱受体(nAChR)进行光标记。
Mol Pharmacol. 2016 May;89(5):575-84. doi: 10.1124/mol.116.103341. Epub 2016 Mar 14.
9
Structural Determinants of Oxantel Analogs Reveal Modulatory Selectivity of α3β2 and α4β2 Neuronal Nicotinic Acetylcholine Receptors.奥克太尔类似物的结构决定因素揭示了α3β2和α4β2神经元烟碱型乙酰胆碱受体的调节选择性。
ACS Omega. 2025 Feb 12;10(7):7338-7349. doi: 10.1021/acsomega.4c11196. eCollection 2025 Feb 25.
10
Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats.选择性增强(α4)3(β2)2 型烟碱型乙酰胆碱受体可增强大鼠前额叶乙酰胆碱和尼古丁诱导的谷氨酸盐瞬变的幅度。
Biochem Pharmacol. 2013 Nov 15;86(10):1487-96. doi: 10.1016/j.bcp.2013.09.005. Epub 2013 Sep 16.

引用本文的文献

1
Structural Determinants of Oxantel Analogs Reveal Modulatory Selectivity of α3β2 and α4β2 Neuronal Nicotinic Acetylcholine Receptors.奥克太尔类似物的结构决定因素揭示了α3β2和α4β2神经元烟碱型乙酰胆碱受体的调节选择性。
ACS Omega. 2025 Feb 12;10(7):7338-7349. doi: 10.1021/acsomega.4c11196. eCollection 2025 Feb 25.
2
Tetrapeptide Ac-HAEE-NH Protects α4β2 nAChR from Inhibition by Aβ.四肽 Ac-HAEE-NH 可保护α4β2 nAChR 免受 Aβ 的抑制。
Int J Mol Sci. 2020 Aug 29;21(17):6272. doi: 10.3390/ijms21176272.
3
Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.通过拟似激动剂部位增强神经元烟碱型受体。
Cell Mol Life Sci. 2019 Mar;76(6):1151-1167. doi: 10.1007/s00018-018-2993-7. Epub 2019 Jan 1.
4
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.同型神经元烟碱型乙酰胆碱受体的变构正位增效作用。
Br J Pharmacol. 2018 Jun;175(11):1805-1821. doi: 10.1111/bph.13745. Epub 2017 Mar 20.
5
Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.亚基界面在神经元烟碱型乙酰胆碱受体的激活和变构调节中发挥不同作用。
Neuropharmacology. 2015 Apr;91:157-68. doi: 10.1016/j.neuropharm.2014.11.027. Epub 2014 Dec 5.
6
Discovery of potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL.通过在ChEMBL中进行化学空间探索发现α3β2烟碱型乙酰胆碱受体的强效正变构调节剂。
ACS Chem Neurosci. 2014 May 21;5(5):346-59. doi: 10.1021/cn4002297. Epub 2014 Mar 4.
7
Intra-subunit flexibility underlies activation and allosteric modulation of neuronal nicotinic acetylcholine receptors.亚基内的灵活性是神经元烟碱型乙酰胆碱受体激活和变构调节的基础。
Neuropharmacology. 2014 Apr;79:420-31. doi: 10.1016/j.neuropharm.2013.12.017. Epub 2013 Dec 25.
8
Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor.毒扁豆碱和加兰他敏与激动剂结合于烟碱型乙酰胆碱受体的经典和非经典亚基界面。
J Neurosci. 2013 Jan 9;33(2):485-94. doi: 10.1523/JNEUROSCI.3483-12.2013.

本文引用的文献

1
Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors.解析烟碱型乙酰胆碱受体的高敏和低敏激动剂反应。
J Neurosci. 2011 Jul 27;31(30):10759-66. doi: 10.1523/JNEUROSCI.1509-11.2011.
2
Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity.在(α4β2)2α4 烟碱型乙酰胆碱受体的α4/α4 界面处的额外乙酰胆碱(ACh)结合位点影响激动剂敏感性。
J Biol Chem. 2011 Sep 2;286(35):31043-31054. doi: 10.1074/jbc.M111.262014. Epub 2011 Jul 14.
3
Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors.靶向人类 α4β2 神经元烟碱型受体的负变构调节剂。
J Pharmacol Exp Ther. 2010 Sep 1;334(3):761-74. doi: 10.1124/jpet.110.168211. Epub 2010 Jun 15.
4
Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator.烟碱型乙酰胆碱受体跨膜突变将伊维菌素从正变构调节剂转变为负变构调节剂。
Mol Pharmacol. 2010 Aug;78(2):198-204. doi: 10.1124/mol.110.064295. Epub 2010 May 12.
5
Binding, activation and modulation of Cys-loop receptors.Cys-loop 受体的结合、激活和调节。
Trends Pharmacol Sci. 2010 Apr;31(4):161-74. doi: 10.1016/j.tips.2009.12.005. Epub 2010 Jan 25.
6
Atomic structure and dynamics of pentameric ligand-gated ion channels: new insight from bacterial homologues.五聚体配体门控离子通道的原子结构与动力学:细菌同源物的新见解。
J Physiol. 2010 Feb 15;588(Pt 4):565-72. doi: 10.1113/jphysiol.2009.183160. Epub 2009 Dec 7.
7
The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors.正变构调节剂莫仑太尔结合于神经元烟碱型乙酰胆碱受体的非典型亚基界面。
J Neurosci. 2009 Jul 8;29(27):8734-42. doi: 10.1523/JNEUROSCI.1859-09.2009.
8
Insight in nAChR subtype selectivity from AChBP crystal structures.从乙酰胆碱结合蛋白晶体结构洞察烟碱型乙酰胆碱受体亚型选择性。
Biochem Pharmacol. 2009 Oct 1;78(7):777-87. doi: 10.1016/j.bcp.2009.06.098. Epub 2009 Jul 1.
9
Glutamine 57 at the complementary binding site face is a key determinant of morantel selectivity for {alpha}7 nicotinic receptors.互补结合位点表面的谷氨酰胺57是莫仑太尔对α7烟碱受体选择性的关键决定因素。
J Biol Chem. 2009 Aug 7;284(32):21478-87. doi: 10.1074/jbc.M109.013797. Epub 2009 Jun 8.
10
Structural and functional diversity of native brain neuronal nicotinic receptors.天然脑神经元烟碱型受体的结构与功能多样性
Biochem Pharmacol. 2009 Oct 1;78(7):703-11. doi: 10.1016/j.bcp.2009.05.024. Epub 2009 May 27.